Body mass index also decreased more with semaglutide compared with placebo, with reductions of 1.5 kg/m versus 0.4 kg/m that were similar regardless of SGLT2i use at baseline ( P -interaction, 0.86)
They can always make it up the next day or skip the next meal as compensation
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicentre study: The LixiLan JP-O2 randomized clinical trial
Finally, people outside the UK wont find access here
Medicine and science in sports and exercise , 49 (1), 206217
Walter Krause Neto, et al